CTRI/2022/03/041273
Not yet recruiting
未知
Study of T regulatory cells in Type 1 and Type 2 Leprosy Reactions
RML HOSPITA0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: A309- Leprosy, unspecified
- Sponsor
- RML HOSPITA
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adult Patients
- •2\. Type 1/ Type 2 reaction
- •3\. Clinically diagnosed
- •4\. Not on treatment for reactions
- •5\. Patients willing to participate
Exclusion Criteria
- •1\. Pregnancy
- •2\. Autoimmune diseases
- •3\. Infectious comorbidities
- •4\. Use of immunosuppressive drugs for other
- •causes than leprosy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phenotype and number of regulatory T cells present in peripheral blood of COPD patients versus healthy controlsNL-OMON30145niversitair Medisch Centrum Groningen50
Completed
Not Applicable
Characterisation of regulatory T cells and cytokine production in children diagnosed with asthmaAirway hyperresponsivenessbronchusobstruction100386861000170810006436NL-OMON33976niversitair Medisch Centrum Utrecht120
Completed
Phase 2
ew regimen of therapy in the treatment of human BrucellosisBrucellosis.Brucellosis due to Brucella melitensisIRCT2014042617430N1Babol University of Medical Sciences60
Completed
Not Applicable
The effect of two different drug protocols on the kidney transplant patients immune systemKidney transplant.Kidney transplant statusIRCT2016062528620N1Molecular Immunology Research Center20
Completed
Not Applicable
Evaluation of regulatory T cell and disease activity after transdermal administration of Dovonex(r) ointment 50ug/g in patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000022296Medical Co.LTA PS Clinic20